Biotech

All Articles

Lilly, Haya ink $1B biobuck excessive weight pact to explore darker genome

.Eli Lilly's search for obesity aim ats has led it to the darker genome. The Big Pharma has actually...

ArsenalBio raises $325M, pivots far from previous lead property

.Collection Biosciences is actually going on up. The cell therapy firm has added $325 million in amm...

Lilly- backed weight loss biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis usage medication flunks period 2b, steering Indivior to rethink $100M option

.Aelis Farma's hopes of getting a quick, favorable choice on a $one hundred thousand choice remittan...

ProKidney halts period 3 test not required for tissue therapy authorization

.ProKidney has actually ceased one of a pair of stage 3 tests for its tissue treatment for renal ill...

Vaxcyte surges on 'magnificent' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals referred to as "spectacular" phase 1/2 information for its own ...

Recursion's mind ailment trial presents little documentation of efficiency

.Recursion has actually discovered through a very early exam of its tech-enabled approach to medicat...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Call it an instance of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy medicine minimizes confiscations in stage 2 trial

.Praxis Precision Medicines has racked up an additional midphase succeed in epilepsy this year, alon...

Three officers resign as Dyne articles mixed data for DMD applicant

.After getting away a clinical hold several years back, Dyne Therapy has actually revealed brand-new...